PORTEC-4a: International randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

ASVM van den Heerik; N Horeweg; Remi Nout; LC Lutgens; E van der Steen-Banasik; GH Westerveld; HA van den Berg; A Slot; FLA Koppe; S Kommoss; Jan Willem Mens; ME Nowee; S Bijmolt; D Cibula; TC Stam; IM Jurgenliemk-Schulz; A Snyers; M Hamann; AG Zwanenburg; VL Coen; K Vandecasteele; C Gillham; C Chargari; KW Verhoeven-Adema; H Putter; WB van den Hout; BG Wortman; HW Nijman; T Bosse; CL Creutzberg

doi:10.1136/ijgc-2020-001929

PORTEC-4a: International randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

ASVM van den Heerik
, N Horeweg
, Remi Nout
, LC Lutgens
, E van der Steen-Banasik
, GH Westerveld
, HA van den Berg
, A Slot
, FLA Koppe
, S Kommoss
, Jan Willem Mens
, ME Nowee
, S Bijmolt
, D Cibula
, TC Stam
, IM Jurgenliemk-Schulz
, A Snyers
, M Hamann
, AG Zwanenburg
, VL Coen

K Vandecasteele, C Gillham, C Chargari, KW Verhoeven-Adema, H Putter, WB van den Hout, BG Wortman, HW Nijman, T Bosse, CL Creutzberg

Radiotherapy

Research output: Contribution to journal › Article › Academic › peer-review

203 Citations (Scopus)

90 Downloads (Pure)

Original language	English
Pages (from-to)	2002-2007
Number of pages	6
Journal	International Journal of Gynecological Cancer
Volume	30
Issue number	12
DOIs	https://doi.org/10.1136/ijgc-2020-001929
Publication status	Published - 2020

Research programs

EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/ijgc-2020-001929

Repub_133894_O-A.pdfFinal published version, 1.42 MB

http://hdl.handle.net/1765/133894

Cite this

van den Heerik, ASVM., Horeweg, N., Nout, R., Lutgens, LC., van der Steen-Banasik, E., Westerveld, GH., van den Berg, HA., Slot, A., Koppe, FLA., Kommoss, S., Mens, J. W., Nowee, ME., Bijmolt, S., Cibula, D., Stam, TC., Jurgenliemk-Schulz, IM., Snyers, A., Hamann, M., Zwanenburg, AG., ... Creutzberg, CL. (2020). PORTEC-4a: International randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer. International Journal of Gynecological Cancer, 30(12), 2002-2007. https://doi.org/10.1136/ijgc-2020-001929

@article{311affc4b344405bb97a1fef56779a01,

title = "PORTEC-4a: International randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer",

author = "\{van den Heerik\}, ASVM and N Horeweg and Remi Nout and LC Lutgens and \{van der Steen-Banasik\}, E and GH Westerveld and \{van den Berg\}, HA and A Slot and FLA Koppe and S Kommoss and Mens, \{Jan Willem\} and ME Nowee and S Bijmolt and D Cibula and TC Stam and IM Jurgenliemk-Schulz and A Snyers and M Hamann and AG Zwanenburg and VL Coen and K Vandecasteele and C Gillham and C Chargari and KW Verhoeven-Adema and H Putter and \{van den Hout\}, WB and BG Wortman and HW Nijman and T Bosse and CL Creutzberg",

year = "2020",

doi = "10.1136/ijgc-2020-001929",

language = "English",

volume = "30",

pages = "2002--2007",

journal = "International Journal of Gynecological Cancer",

issn = "1048-891X",

publisher = "Elsevier Inc.",

number = "12",

}

van den Heerik, ASVM, Horeweg, N, Nout, R, Lutgens, LC, van der Steen-Banasik, E, Westerveld, GH, van den Berg, HA, Slot, A, Koppe, FLA, Kommoss, S, Mens, JW, Nowee, ME, Bijmolt, S, Cibula, D, Stam, TC, Jurgenliemk-Schulz, IM, Snyers, A, Hamann, M, Zwanenburg, AG, Coen, VL, Vandecasteele, K, Gillham, C, Chargari, C, Verhoeven-Adema, KW, Putter, H, van den Hout, WB, Wortman, BG, Nijman, HW, Bosse, T & Creutzberg, CL 2020, 'PORTEC-4a: International randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer', International Journal of Gynecological Cancer, vol. 30, no. 12, pp. 2002-2007. https://doi.org/10.1136/ijgc-2020-001929

TY - JOUR

T1 - PORTEC-4a: International randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

AU - van den Heerik, ASVM

AU - Horeweg, N

AU - Nout, Remi

AU - Lutgens, LC

AU - van der Steen-Banasik, E

AU - Westerveld, GH

AU - van den Berg, HA

AU - Slot, A

AU - Koppe, FLA

AU - Kommoss, S

AU - Mens, Jan Willem

AU - Nowee, ME

AU - Bijmolt, S

AU - Cibula, D

AU - Stam, TC

AU - Jurgenliemk-Schulz, IM

AU - Snyers, A

AU - Hamann, M

AU - Zwanenburg, AG

AU - Coen, VL

AU - Vandecasteele, K

AU - Gillham, C

AU - Chargari, C

AU - Verhoeven-Adema, KW

AU - Putter, H

AU - van den Hout, WB

AU - Wortman, BG

AU - Nijman, HW

AU - Bosse, T

AU - Creutzberg, CL

PY - 2020

Y1 - 2020

U2 - 10.1136/ijgc-2020-001929

DO - 10.1136/ijgc-2020-001929

M3 - Article

C2 - 33046573

SN - 1048-891X

VL - 30

SP - 2002

EP - 2007

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

IS - 12

ER -